If your clinical trial includes sites in the United Kingdom as well as EU participating countries, have you taken steps to assure uninterrupted supply and to mitigate risk of patient impact?
Sponsors must establish a clinical supply chain with distribution in both the UK and EU in accordance with local regulations and quality standards.
Download this Infographic for a ‘quick reference’ of key steps to ensure readiness in the areas of:
- Facility / Capacity considerations
- Quality requirements
- Regulatory impacts